Pay in 4 interest-free payments of $7.33 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications originally developed for type 2 diabetes management, though some specific formulations are now licensed for weight management in adults with obesity or overweight with weight-related comorbidities
Dietary quality is arguably the most important modifiable factor
Avoid shaking during reconstitution
Hypothesis 4 Body composition Retatrutide's glucagon-receptor activation drives some of its weight loss through increased energy expenditure, which is mechanistically associated with sparing more lean mass than pure-satiety pathways
US$ 22.93
US$ 25.22
US$ 21.78
US$ 23.18
